Health Care Technology
Company Overview of NextGxDx Inc.
NextGxDx Inc. operates as a healthcare IT company that focuses on enhancing the genetic test ordering process for the medical community. Its portfolio includes GeneSource, a tool available for physicians and other healthcare professionals to search for, compare, and order genetic tests from various laboratories; and GeneConnect, a utilization management solution that leverages the GeneSource database and provides hospitals and sendout laboratories with the tools to lower costs and address workflow inefficiencies associated with the genetic test ordering process. The company was founded in 2010 and is based in Franklin, Tennessee.
810 Crescent Centre Drive
Franklin, TN 37067
Founded in 2010
Key Executives for NextGxDx Inc.
Founder, Chief Innovation Officer and Director
Senior Vice President of Business Development
Compensation as of Fiscal Year 2016.
NextGxDx Inc. Key Developments
NextGxDx Inc. Announces Executive Changes
Jul 8 16
Mark Harris announced that Rob Metcalf has succeeded him as chief executive officer of NextGxDx. Harris, who founded the healthcare information technology company in 2010, has elected to take a new leadership position, chief innovation officer, where his primary focus will be developing the next wave of transformative solutions for the genetic testing market. Metcalf brings more than a decade of experience leading technology and information services businesses. Most recently, he served as president and chief operating officer for Digital Reasoning. Metcalf's prior roles include multiple positions with LexisNexis, including vice president of global operations for the company's practice management division.
Novation Awards Group Purchasing Contract to NextGxDx, Inc
Sep 16 15
Novation announced that it has awarded a group purchasing contract to NextGxDx Inc. Under the agreement, Children's Hospital Association (CHA) members who participate with Novation will have access to NextGxDx's GeneConnect genetic testing utilization management solution, as well as the resources available through NextGxDx's collaboration with the Seattle Children's Hospital PLUGS (Pediatric Laboratory Utilization Guidance Services) program. In addition to GeneConnect, the Novation agreement includes NextGxDx's collaboration with the Seattle Children's Hospital's PLUGS program, which helps clinical laboratories and hospitals improve the value of laboratory tests by reducing costs and errors associated with unnecessary testing. PLUGS members are provided a customized strategic plan on how to develop and sustain an internal utilization management program, as well as access to practical tools, expert advice and to the valuable PLUGS peer network.
Seattle Children's Hospital Collaborates with NextGxDx, Inc. to Develop a Joint Genetic Test Utilization Management
Jun 25 15
Seattle Children's Hospital announced that it will collaborate with NextGxDx Inc. to develop a joint genetic test utilization management (UM) solution for children's hospitals and pediatric practices. The collaboration will combine the hospital's PLUGS UM program and its team of genetic testing experts with NextGxDx's GeneConnect platform, a technology solution designed to bring highly specialized data and tools to help curb rising genetic testing send-out costs. The collaboration was announced at the first annual PLUGS Summit Utilization Management Conference. PLUGS, which stands for Pediatric Laboratory Utilization Guidance Services, helps clinical laboratories and practitioners decrease costs and errors associated with unnecessary laboratory testing by providing practical resources, expert advice and a valuable peer network for members to develop sustainable utilization management programs.
Similar Private Companies By Industry
Recent Private Companies Transactions
August 22, 2016